Source: freestylephoto/Getty Images

20 Molecular Diagnostics Companies to Watch

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.

Immune System Gene Could Be Prognostic Marker for CRC

The gene, CCR4, was present in higher levels in patients with a good prognosis, even in those diagnosed with late stage colorectal cancer.
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
Clinician Offering Drugs Based On DNA Profiling

FDA Sends Warning Letter to Inova Over Pharmacogenomics Test

The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.

PerkinElmer, Helix Partner to Launch Genetic Screening Test

The DNA test available to healthy individuals analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics.

Wearable Data Revolution

There is no doubt the age of wearable monitors is upon us. Sales of physical activity monitors have increased dramatically from 15 million in...
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine

Five-Year Super Successes in Genomics and Precision Medicine

Multidimensional, computationally rich approaches represent the next wave of innovation, taking personalized medicine to the next level, while demanding more of practitioners, who in...

New AACR President Elaine Mardis Talks Precision Medicine, Cancer Research with Clinical OMICs

A leader in cancer genomics research, new AACR president recaps her research over the past five years and looks ahead to what advances my lie ahead.

LabCorp’s Covance to Offer Services via Mission Bio’s Tapestri Platform

LabCorp’s Covance Drug Development business will be the first global contract research organization to offer services on Mission Bio’s Tapestri Platform for single-cell DNA genomics.
Scroll Up